This year, the atopic eczema community is coming together to explore five major burdens of the condition:
- The burden of extreme physical pain and itch
- The burden on families and caregivers
- The burden on finances
- The burden on mental health
- The burden of daily management
In the following video, members of our Atopic Dermatitis (AD) Therapy Monitor team share recent insights from our syndicated AD study portfolio, and our Social Listening Intelligence platform, that centre around each of the five burdens from both a physician and patient / caregiver perspective. We also include pertinent take-away messages from our recent attendance at EADV 2022.
A new era in multiple sclerosis
Momentum continues to build in the use of high-efficacy, disease modifying therapies (DMTs) as a first choice for treating multiple sclerosis. How is this being influenced by the availability of anti-CD20s, a new class of DMT? Will future new therapy classes change the paradigm even further?